Rachel Overman | JPM CBRN Medical

Ms. Rachel Overman oversees the development of the antiviral and countermeasures for multi-drug resistance bacteria. She leads multi-functional teams and collaborates with joint service, interagency, international teams of scientists, and acquisition professionals in the development, acquisition, and fielding of U.S. Food and Drug Administration-approved CBRN medical countermeasures.